Skip to main content
. 2021 Aug 26;132(5):933–941. doi: 10.1002/lary.29766

Table II.

SNOT‐22 Inter‐Domain Correlations and Domain Reliability.

SNOT‐22 Domain Pearson Correlations at Baseline, Phase 3 Cronbach's Alpha at Baseline, Phase 2/Phase 3 Test–Retest ICC (95% CI), Phase 2/Phase 3
Nasal Ear/Facial Sleep Function Emotion No Change on RS VAS * No Change on NPS
Nasal 1.0 0.84/0.83 0.82 (0.69, 0.90)/0.86 (0.84, 0.88) 0.83 (0.66, 0.92)/0.84 (0.80, 0.88)
Ear/facial 0.699 1.0 0.81/0.81 0.84 (0.72, 0.91)/0.76 (0.72, 0.80) 0.76 (0.54, 0.88)/0.76 (0.70, 0.81)
Sleep 0.609 0.686 1.0 0.89/0.91 0.88 (0.78, 0.94)/0.77 (0.74, 0.81) 0.86 (0.71, 0.93)/0.78 (0.72, 0.83)
Function 0.554 0.731 0.877 1.0 0.90/0.92 0.90 (0.82, 0.95)/0.75 (0.71, 0.79) 0.91 (0.81, 0.96)/0.78 (0.72, 0.83)
Emotion 0.533 0.707 0.749 0.870 1.0 0.87/0.86 0.84 (0.71, 0.91)/0.80 (0.76, 0.83) 0.85 (0.70, 0.93)/0.80 (0.75, 0.85)
Total 0.94/0.94 0.92 (0.85, 0.96)/0.86 (0.84, 0.88) 0.89 (0.77, 0.95)/0.85 (0.81, 0.88)
*

No change in rhinosinusitis VAS categories between Week 8 and Week 12.

No change in NPS between Week 8 and Week 12.

CI = confidence interval; ICC = intraclass correlation coefficient; NPS = Nasal Polyps Score; RS VAS = rhinosinusitis Visual Analog Scale; SNOT‐22 = 22‐item Sinonasal Outcome Test.